Anuh Pharma schedules 66th AGM on August 12, 2026

1 min read     Updated on 21 Jul 2026, 09:42 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Anuh Pharma Limited has scheduled its 66th Annual General Meeting for August 12, 2026, via video conferencing to adopt financial statements for FY26 and declare a final dividend. The record date for dividend entitlement is August 5, 2026, with the register of members closing from August 6 to August 12. Remote e-voting facilities are available from August 9, 2026, at 9:00 a.m. to August 11, 2026, at 5:00 p.m.

powered bylight_fuzz_icon
45917746

*this image is generated using AI for illustrative purposes only.

Anuh Pharma Ltd has scheduled its 66th Annual General Meeting (AGM) for August 12, 2026, at 4:00 p.m. via video conferencing. The meeting will be held to transact business including the adoption of financial statements for the financial year ended March 31, 2026, and the declaration of a final dividend. Shareholders registered on the books of the company as of the cut-off date of August 5, 2026, are eligible to participate and vote.

The register of members and share transfer books will remain closed from August 6, 2026, to August 12, 2026, to determine shareholder entitlement for the dividend. The company has provided a remote e-voting facility, which will commence on August 9, 2026, at 9:00 a.m. and conclude on August 11, 2026, at 5:00 p.m. Members attending the meeting through video conferencing who have not voted remotely may cast their votes electronically during the AGM.

Key AGM Dates

Event Date
Record Date August 5, 2026
AGM Date August 12, 2026
E-voting Commencement August 9, 2026
E-voting End August 11, 2026

The Notice of the AGM and the Annual Report for the Financial Year 2025-26 will be sent electronically to members and will be available on the company's website. The company has requested members to ensure their email addresses are registered with the company or their depository participants to receive login credentials for e-voting.

Historical Stock Returns for Anuh Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.48%-1.34%+0.23%+8.66%-20.76%-29.04%

What dividend payout ratio can shareholders expect based on Anuh Pharma's recent financial performance?

How might the company's strategic initiatives for FY2026-27 impact its long-term growth trajectory?

What are the potential market reactions to the financial statements and dividend announcement?

Anuh Pharma receives ₹17.46 lakh tax demand for AY 2020-21

1 min read     Updated on 20 Jun 2026, 04:06 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Anuh Pharma Limited received a tax demand and penalty order of ₹17.46 lakhs for Assessment Year 2020-21 from the Income Tax Department. The order, received on June 18, 2026, arises from disallowances of certain deductions claimed under the Income Tax Act. The company stated it will file an appeal before the Higher Appellate Forums and believes there is no impact on its financial operations.

powered bylight_fuzz_icon
43417835

*this image is generated using AI for illustrative purposes only.

Anuh Pharma Limited has received a tax demand and penalty order of ₹17.46 lakhs for Assessment Year 2020-21 from the Income Tax Department. The order was issued under Section 156 and Section 270 of the Income Tax Act, 1961, following a scrutiny assessment. The company stated that the demand arises from disallowances of certain deductions claimed under various provisions of the Income Tax Act.

The order was received by the company on June 18, 2026. The total demand of ₹17.46 lakhs includes a penalty under Section 270A(9) read with Section 270A(8) of the Income Tax Act.

Company Response

Anuh Pharma disclosed that it is in the process of filing an appeal before the Higher Appellate Forums against the said order within the prescribed timelines. The management believes it has adequate factual and legal grounds to substantiate its position in the matter.

The company further stated that, based on its assessment, there is no impact on the financial operations or other activities of the company. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Details of the Order

Particulars Details
Name of the Authority Income Tax Department, Assessment Unit
Nature of Order Penalty Order under section 270A
Date of Receipt June 18, 2026
Violation/Contravention Disallowances of certain deductions claimed under various provisions of the Income Tax Act
Financial Impact ₹17.46 lakhs

Historical Stock Returns for Anuh Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.48%-1.34%+0.23%+8.66%-20.76%-29.04%

How might the outcome of this appeal influence Anuh Pharma's future tax compliance strategies?

Could this scrutiny assessment lead to similar tax demands for other assessment years?

What is the expected timeline for the resolution of the appeal, and how might it affect investor sentiment?

More News on Anuh Pharma

1 Year Returns:-20.76%